Boston Scientific's VICI VENOUS STENT System Meets Primary Endpoints at 1 Year

Posted in

January 23, 2019 • 3 min read

Today, Boston Scientific announced positive 12-month data demonstrating that patients who were treated with the VICI VENOUS STENT System for iliac and femoral vein obstructions exhibited a high rate of patent, or open, target lesions. Primary safety and efficacy results from the VIRTUS trial...

Verily Study Watch Receives FDA 510(k) Clearance for ECG

Posted in

January 22, 2019 • 2 min read

In late 2018, Apple received FDA Clearance for their ECG app on the Apple Watch Series 4. Now Verily, part of Google's parent company, Alphabet, announced that the Verily Study Watch has received 510(k) clearance from the FDA as a Class II medical device for its on-demand ECG feature....

FDA Issues Letter About Paclitaxel Coated Balloons and Eluting Stents

Posted in

January 18, 2019 • 2 min read

Today the FDA issued a Letter to Health Care Providers about a recent publication in the Journal of the American Heart Association that suggests a possible increased risk of death at two years and beyond in patients with a type of peripheral arterial disease (PAD)...

Abbott Acquires Cephea Valve Technologies

Posted in

January 16, 2019 • 2 min read

Abbott ($ABT) announced today that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company developing a less-invasive heart valve replacement technology...

This artificial heart can save the youngest patients

Posted in

January 15, 2019